48 related articles for article (PubMed ID: 23163758)
1. Survival of patients with clear cell renal carcinoma according to number and location of organ-specific metastatic sites.
Tappero S; Barletta F; Piccinelli ML; Cano Garcia C; Incesu RB; Morra S; Scheipner L; Baudo A; Tian Z; Parodi S; Dell'Oglio P; Briganti A; de Cobelli O; Chun FKH; Graefen M; Longo N; Ahyai S; Carmignani L; Saad F; Shariat SF; Suardi N; Borghesi M; Terrone C; Karakiewicz PI
Urol Oncol; 2024 Jan; 42(1):22.e23-22.e31. PubMed ID: 37775340
[TBL] [Abstract][Full Text] [Related]
2. Tumour Evolution and Seed and Soil Mechanism in Pancreatic Metastases of Renal Cell Carcinoma.
Sellner F; Thalhammer S; Klimpfinger M
Cancers (Basel); 2021 Mar; 13(6):. PubMed ID: 33809634
[TBL] [Abstract][Full Text] [Related]
3. Spontaneous regression of multiple pulmonary metastases accompanied by normalization of serum immune markers following cytoreductive nephrectomy in a patient with clear-cell renal cell carcinoma.
Okazaki A; Kijima T; Schiller P; Ishikawa N; Fuchizawa H; Takei K; Suzuki I; Sakamoto K; Tsuzuki T; Kamai T
IJU Case Rep; 2021 Mar; 4(2):95-99. PubMed ID: 33718815
[TBL] [Abstract][Full Text] [Related]
4. A unique presentation of a renal clear cell carcinoma with atypical metastases.
Staderini F; Cianchi F; Badii B; Skalamera I; Fiorenza G; Foppa C; Qirici E; Perigli G
Int J Surg Case Rep; 2015; 11():29-32. PubMed ID: 25911241
[TBL] [Abstract][Full Text] [Related]
5. A case of hypervascular tumors in the liver and pancreas: synchronous hepatocellular carcinoma and pancreatic metastasis from renal cell carcinoma 36 years after nephrectomy.
Nakamura H; Tanaka S; Miyanishi K; Kawano Y; Osuga T; Ishikawa K; Yoshida M; Ohnuma H; Murase K; Takada K; Yamaguchi H; Nagayama M; Kimura Y; Takemasa I; Kato J
Clin Case Rep; 2021 Feb; 9(2):932-937. PubMed ID: 33598275
[TBL] [Abstract][Full Text] [Related]
6. Editorial Comment to Spontaneous regression of multiple pulmonary metastases accompanied by normalization of serum immune markers following cytoreductive nephrectomy in a patient with clear-cell renal cell carcinoma.
Ohba K
IJU Case Rep; 2021 Mar; 4(2):100. PubMed ID: 33718816
[No Abstract] [Full Text] [Related]
7. Biological resonance for cancer metastasis, a new hypothesis based on comparisons between primary cancers and metastases.
Gao D; Li S
Cancer Microenviron; 2013 Dec; 6(3):213-30. PubMed ID: 24214411
[TBL] [Abstract][Full Text] [Related]
8. The Association Between Small Primary Tumor Size and Prognosis in Metastatic Renal Cell Carcinoma: Insights from Two Independent Cohorts of Patients Who Underwent Cytoreductive Nephrectomy.
DiNatale RG; Xie W; Becerra MF; Silagy AW; Attalla K; Sanchez A; Mano R; Marcon J; Blum KA; Benfante NE; Voss MH; Motzer RJ; Coleman J; Choueiri TK; Reznik E; Russo P; Heng DYC; Hakimi AA
Eur Urol Oncol; 2020 Feb; 3(1):47-56. PubMed ID: 31735646
[TBL] [Abstract][Full Text] [Related]
9. The Role of Cytoreductive Nephrectomy for Sarcomatoid Renal Cell Carcinoma: A 29-Year Institutional Experience.
Silagy AW; Mano R; Blum KA; DiNatale RG; Marcon J; Tickoo SK; Reznik E; Coleman JA; Russo P; Hakimi AA
Urology; 2020 Feb; 136():169-175. PubMed ID: 31726184
[TBL] [Abstract][Full Text] [Related]
10. Kidney Cancer Research Network of Canada (KCRNC) consensus statement on the role of cytoreductive nephrectomy for patients with metastatic renal cell carcinoma.
Mason RJ; Wood L; Kapoor A; Basappa N; Bjarnason G; Boorjian SA; Breau RH; Cagiannos I; Jewett MAS; Karakiewicz PI; Kassouf W; Kollmannsberger C; Lalani AA; Lattouf JB; Lavallée LT; Pautler S; Power N; Richard P; So A; Tanguay S; Rendon RA
Can Urol Assoc J; 2019 Jun; 13(6):166-174. PubMed ID: 31199235
[No Abstract] [Full Text] [Related]
11. Survival of metastatic renal cell carcinoma patients continues to improve over time, even in targeted therapy era.
Marchioni M; Bandini M; Pompe RS; Tian Z; Martel T; Kapoor A; Cindolo L; Berardinelli F; Briganti A; Shariat SF; Schips L; Karakiewicz PI
Int Urol Nephrol; 2017 Dec; 49(12):2143-2149. PubMed ID: 28932952
[TBL] [Abstract][Full Text] [Related]
12.
Alhamhoom Y; Zhang G; Gao M; Cai H; Liu D
Am J Cancer Res; 2017; 7(2):301-311. PubMed ID: 28337378
[TBL] [Abstract][Full Text] [Related]
13. New challenges in kidney cancer management: integration of surgery and novel therapies.
Puente Vázquez J; Alonso Gordoa T; Moreno J; Poma L; Diaz Rubio E; Gomez A; Blazquez J; Gonzalez Larriba JL
Curr Treat Options Oncol; 2015 Mar; 16(3):337. PubMed ID: 25782687
[TBL] [Abstract][Full Text] [Related]
14. Partial nephrectomy in the setting of metastatic renal cell carcinoma.
Babaian KN; Merrill MM; Matin S; Tamboli P; Tannir NM; Jonasch E; Wood CG; Karam JA
J Urol; 2014 Jul; 192(1):36-42. PubMed ID: 24518767
[TBL] [Abstract][Full Text] [Related]
15. Effect of number and location of distant metastases on renal cell carcinoma mortality in candidates for cytoreductive nephrectomy: implications for multimodal therapy.
Capitanio U; Abdollah F; Matloob R; Salonia A; Suardi N; Briganti A; Carenzi C; Rigatti P; Montorsi F; Bertini R
Int J Urol; 2013 Jun; 20(6):572-9. PubMed ID: 23163758
[TBL] [Abstract][Full Text] [Related]
16. Impact of synchronous metastasis distribution on cancer specific survival in renal cell carcinoma after radical nephrectomy with tumor thrombectomy.
Tilki D; Hu B; Nguyen HG; Dall'Era MA; Bertini R; Carballido JA; Chandrasekar T; Chromecki T; Ciancio G; Daneshmand S; Gontero P; Gonzalez J; Haferkamp A; Hohenfellner M; Huang WC; Koppie TM; Linares E; Lorentz CA; Mandel P; Martinez-Salamanca JI; Master VA; Matloob R; McKiernan JM; Mlynarczyk CM; Montorsi F; Novara G; Pahernik S; Palou J; Pruthi RS; Ramaswamy K; Rodriguez Faba O; Russo P; Shariat SF; Spahn M; Terrone C; Thieu W; Vergho D; Wallen EM; Xylinas E; Zigeuner R; Libertino JA; Evans CP
J Urol; 2015 Feb; 193(2):436-42. PubMed ID: 25063493
[TBL] [Abstract][Full Text] [Related]
17. Cytoreductive nephrectomy for metastatic renal cell carcinoma with nonclear cell histology.
Kassouf W; Sanchez-Ortiz R; Tamboli P; Tannir N; Jonasch E; Merchant MM; Matin S; Swanson DA; Wood CG
J Urol; 2007 Nov; 178(5):1896-900. PubMed ID: 17868729
[TBL] [Abstract][Full Text] [Related]
18. Number of metastatic sites rather than location dictates overall survival of patients with node-negative metastatic renal cell carcinoma.
Han KR; Pantuck AJ; Bui MH; Shvarts O; Freitas DG; Zisman A; Leibovich BC; Dorey FJ; Gitlitz BJ; Figlin RA; Belldegrun AS
Urology; 2003 Feb; 61(2):314-9. PubMed ID: 12597937
[TBL] [Abstract][Full Text] [Related]
19. The role of surgery in advanced renal cell carcinoma: cytoreductive nephrectomy and metastasectomy.
Karam JA; Wood CG
Hematol Oncol Clin North Am; 2011 Aug; 25(4):753-64. PubMed ID: 21763966
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
